Nan Lin

Title: The Innovations of Nan Lin

Introduction

Nan Lin is a prominent inventor based in St. Louis, MO (US). He has made significant contributions to the field of biotechnology, holding a total of 5 patents. His work focuses on developing advanced cell lines that enhance the production of biologics and recombinant proteins.

Latest Patents

Among his latest patents is the invention titled "Viral resistant cells and uses thereof." This invention provides mammalian cell lines that have been genetically engineered to resist viral entry and propagation. It also outlines methods for using these cell lines to reduce or prevent viral contamination in biologic production systems. Another notable patent is "Production of recombinant proteins with simple glycoforms." This invention offers cell lines deficient in mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I (Mgat1). It includes methods for producing these Mga1 deficient cell lines and utilizing them for the production of recombinant proteins with simple glycoforms.

Career Highlights

Nan Lin is currently employed at Sigma-Aldrich Co. LLC, where he continues to innovate and contribute to the field of biotechnology. His work has been instrumental in advancing the capabilities of cell lines used in various biological applications.

Collaborations

He collaborates with notable colleagues, including Henry George and Kevin Kayser, who share his commitment to advancing biotechnological research and development.

Conclusion

Nan Lin's contributions to biotechnology through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in biologic production and recombinant protein development.